"10.1371_journal.pone.0071634","plos one","2013-08-23T00:00:00Z","Shyra J Gardai; Wenxian Mao; Birgitt Sch√ºle; Michael Babcock; Sue Schoebel; Carlos Lorenzana; Jeff Alexander; Sam Kim; Heather Glick; Kathryn Hilton; J Kent Fitzgerald; Manuel Buttini; San-San Chiou; Lisa McConlogue; John P Anderson; Dale B Schenk; Frederique Bard; J William Langston; Ted Yednock; Jennifer A Johnston","Elan Pharmaceuticals, Research, South San Francisco, California, United States of America; The Parkinsons Institute, Sunnyvale, California, United States of America","Conceived and designed the experiments: SG WM BS M. Buttini SS CL JKF SSC LM JPA DBS FB JWL TY JJ. Performed the experiments: SG WM M. Babcock SS CL JA SK HG JKF SSC. Analyzed the data: SG WM BS M. Babcock SS CL JA HG JKF SSC. Contributed reagents/materials/analysis tools: M. Buttini SS KH M. Babcock. Wrote the paper: SG BS JWL TY JJ.","Author and co-authors are or were employees and/or shareholders of Elan Pharmaceuticals, Janssen Alzheimer Immunotherapy R& D, or Prothena Biosciences. A preliminary patent application has been filed on the utilization of phagocytosis as a possible early biomarker for Parkinsons Disease. This preliminary filing did not alter the authors adherences to all of PLOS ONEs policies on sharing data and materials.","2013","08","Shyra J Gardai","SJG",20,TRUE,4,3,4,5,TRUE,TRUE,TRUE,10,"5;6;7;8;9;10;11;13;15;17",TRUE
